Arevirumab

N/A

Report date: 2024/12/11 10:49:23

Base Information

Drug NameArevirumab
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionLassa virus inhibitors
TargetsLassa virus
Therapy Area/IndicationsLassa Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsLassa Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A